# Pediatric Oral Iron Therapy: Choosing the Right Product for Your Patient

## TL;DR

This review discusses different oral iron products for treating iron deficiency anemia in children, focusing on effectiveness, tolerance, and safety.

## Contribution

The paper provides a comparative overview of oral iron products for pediatric use, highlighting newer formulations with better tolerance and safety.

## Key findings

- Ferrous sulfate is widely used but has more gastrointestinal side effects compared to newer iron complexes.
- Intermittent dosing of ferrous sulfate is as effective as daily dosing with fewer side effects.
- Liposomal and sucrosomial iron products show better tolerance but lack sufficient pediatric data.

## Abstract

In this narrative review, we address the prevention and therapy of iron deficiency anemia (IDA) with oral iron products in pediatric patients. Fortification of complementary foods with iron-containing micronutrient powders is the preferred method for the prevention of IDA in resource-limited settings. In developed countries, the prevention of sideropenia is through the consumption of iron-rich foods of animal origin. Regarding oral iron therapy, ferrous sulfate is the most widely used and cheapest product, but it is less well tolerated due to gastrointestinal side effects compared to complexes of ferric iron with polysaccharides, and complexes of iron with amino acids in casein, such as iron protein succinylate and iron acetyl aspartylate. These latter products are expensive and available only as single-dose vials with a fixed amount of elemental iron. Intermittent administration of ferrous sulfate, once or twice a week, is equally effective to daily therapy, with fewer side effects, and can be used in selected patients. Oral carbonyl iron has excellent bioavailability and the additional advantage of a high safety margin in cases of accidental overdose compared to iron salts, an important consideration given the potentially lethal consequences of iron overdose. Newer liposomal and sucrosomial iron products appear to have better intestinal tolerance and similar efficacy in the treatment of IDA, but limited pediatric data exist. In conclusion, all oral medicinal iron products are effective when prescribed for the treatment of IDA, if well-absorbed and taken consistently for 3 to 6 months. Physicians should be prepared to use alternative oral agents with better tolerance in case of gastrointestinal side effects.